Welcome to the new Gustave Roussy website
A new website designed to offer you a simpler, clearer, and more intuitive experience. Patients, caregivers, healthcare professionals, and donors: find information, news, and services more easily.
News
113 news
-
16 Researchers from Gustave Roussy Among the Most Influential in the World
Awards & HonoursEach year, Clarivate / Web of Science publishes a list of the most cited researchers worldwide, categorized into 21 fields. Once again, Gustave Roussy and its Foundation rank among the...
-
Gustave Roussy’s General Director, an ambassador of French excellence in the “MAKE IT ICONIC. Choose France” campaign
InstitutionalProfessor Fabrice Barlesi is one of the key figures in the “MAKE IT ICONIC. Choose France” campaign, which promotes French audacity and innovation on a global scale.
-
Gustave Roussy, the first cancer research and treatment center in France and Europe, maintains its position in the top 5 hospitals for oncology globally
InstitutionalFor the fifth consecutive year, Newsweek magazine has ranked Gustave Roussy among the top five hospitals for oncology worldwide, highlighting its outstanding performance in both patient...
-
Gustave Roussy at ESMO Congress 2024
InstitutionalBringing together more than 31,000 international experts, the European Society of Medical Oncology (ESMO) annual congress is one of the highlights of global oncology. This year, it will...
-
Gustave Roussy at the ASCO 2024 conference: a particularly rich edition
Congresses, Conferences & EventsFrom 31 May to 4 June, ASCO, the world’s largest cancer conference, is held in Chicago, USA. This year, Gustave Roussy’s physician-researchers participated in more than 130 abstracts...
-
Transatlantic exchanges: a third edition dedicated to liquid biopsy in cancer treatment
Partnerships & Health EconomicsThe third edition of the Transatlantic Exchanges will be held in Boston on April 12th, 2024. Broadcast online live, this day of exchanges is an opportunity to follow high-level debates...
-
Promising treatments in oncology : Gustave Roussy is at the ESMO TAT congress
Clinical & Scientific AdvancesLe congrès ESMO Targeted Anticancer Therapies (TAT), organisé annuellement en Europe depuis 2018, est un événement incontournable dans le champ des nouvelles cibles et des nouveaux...
-
The FOSTER-CabOs project has received funding for a clinical trial concerning osteosarcoma
Partnerships & Health EconomicsThe ARC Foundation, which has joined forces with four European cancer charities under the ATTRACT grant, awards funding to the FOSTER-CabOS project. The grant obtained through this call...
8 results per page